ondansetron has been researched along with Acute Coronary Syndrome in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guigui, N | 1 |
| Luyt, CE | 1 |
| Vincent, F | 1 |
1 review available for ondansetron and Acute Coronary Syndrome
| Article | Year |
|---|---|
Coronary spasm after injection of ondansetron: case report and review of the literature.
Topics: Acute Coronary Syndrome; Coronary Vasospasm; Cyclophosphamide; Electrocardiography; Female; Follow-U | 2008 |